SCHEMBL3670065

SCHEMBL3670065

Cc1cncc(C(CNC2=NCCO2)c2cccc(C)c2C)c1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.38
ADRA2A P08913 4/20 0.34
ADRA1A P35348 4/20 0.34
CFB P00751 1/20 0.33
P2RX7 Q99572 1/20 0.30
ADRA2B P18089 2/20 0.30
ADRA2C P18825 2/20 0.30
ADRA1D P25100 2/20 0.30
ADRA1B P35368 2/20 0.30
KCNH2 Q12809 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3669311 0.86 CFB (0.36) TAAR1ADRA2AADRA1ACFBP2RX7
SCHEMBL3665641 0.86 ADRA2A (0.33) TAAR1ADRA2AADRA1ACFB
SCHEMBL3415731 0.86 TAAR1 (0.43) TAAR1ADRA2AADRA1ACFBADRA2B
SCHEMBL3668500 0.81 CFB (0.35) TAAR1ADRA2AADRA1ACFBTP53
SCHEMBL3673071 0.80 ADRA2A (0.47) TAAR1ADRA2AADRA1A
SCHEMBL3667158 0.77 TAAR1 (0.40) TAAR1ADRA2AADRA1ACFBADRA2B
SCHEMBL3673459 0.75 P2RX7 (0.41) CFBP2RX7
SCHEMBL3672714 0.75 IDH1 (0.32)
SCHEMBL3670063 0.75 TAAR1 (0.36) TAAR1ADRA2AADRA1ACFBADRA2B
SCHEMBL3433522 0.74 CFB (0.41) TAAR1ADRA2AADRA1ACFBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2242753-A1 OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2010-10-27 EP disclosed
WO-2009091760-A1 OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2009-07-23 WO disclosed